The Oncology Institute Announces First Quarter 2026 Earnings Release Date and Conference Call
Rhea-AI Summary
The Oncology Institute (NASDAQ: TOI) will release first quarter 2026 financial results on Thursday, May 7, 2026, followed by a conference call the same day at 5:30 p.m. ET. A live dial-in, international numbers, and a simultaneous webcast via the Investor Relations website are provided.
A replay will be available two hours after the call through Thursday, May 21, 2026 using the provided replay numbers and passcode 11161701.
Positive
- None.
Negative
- None.
News Market Reaction – TOIIW
In the Apr 27 session, TOIIW declined 0.36%, reflecting a mild negative market reaction.
Data tracked by StockTitan Argus on the day of publication.
Key Figures
Previous Conferences,earnings date Reports
| Date | Event | Sentiment | 24h Move | Catalyst |
|---|---|---|---|---|
| Feb 26 | Earnings date notice | Neutral | +12.4% | Set date and time for Q4 and full-year 2025 results conference call. |
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
For similar earnings-date conference call announcements, the stock previously showed a double-digit positive reaction.
Recent news for The Oncology Institute includes strong Q4 and full-year 2025 results with 2026 guidance on Mar 12, 2026, and multiple operational milestones in April 2026. A prior earnings-release-date announcement on Feb 26, 2026 (for Q4 and FY 2025 results) coincided with a 12.37% move, suggesting that even scheduling notices for results have drawn investor attention historically.
AI-generated analysis. How Rhea-AI works. Not financial advice.
CERRITOS, Calif., April 27, 2026 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. (“TOI”) (NASDAQ: TOI) a pioneer in value-based community oncology care, today announced that the company will release its first quarter 2026 financial results on Thursday, May 7, 2026, to be followed by a conference call the same day at 5:30 p.m. (Eastern Time).
The conference call can be accessed live over the phone by dialing 1-800-225-9448 or for international callers, 1-203-518-9708. A replay will be available two hours after the call and can be accessed by dialing 1-844-512-2921, or for international callers, 1-412-317-6671. The passcode for the live call and the replay is 11161701. The replay will be available until Thursday May 21, 2026.
Interested investors and other parties may also listen to a simultaneous webcast of the conference call by logging onto the Investor Relations section of the Company’s website at https://investors.theoncologyinstitute.com/.
About The Oncology Institute
Founded in 2007, The Oncology Institute (NASDAQ: TOI) is advancing oncology by delivering highly specialized, value-based cancer care in the community setting. TOI offers cutting-edge, evidence-based cancer care to a population of approximately 1.9 million patients, including clinical trials, transfusions, and other care delivery models traditionally associated with the most advanced care delivery organizations. With over 180 employed and affiliate clinicians and over 100 clinics and affiliate locations of care across five states and growing, TOI is changing oncology for the better.
Contacts
Media
The Oncology Institute, Inc.
marketing@theoncologyinstitute.com
Investors
ICR Healthcare
TOI@icrhealthcare.com
